Skip to main content

Table 1 Patient characteristics

From: Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study

  Whole cohort Patients with tissue specimens Patients with serum specimens
Number of specimens, n (%)
Age in years 982 (100) 943 (100) 104 (100)
 0–19 24 (2) 24 (3) 1 (1)
 20–39 133 (14) 125 (13) 16 (15)
 40–59 510 (52) 487 (52) 64 (62)
 60+ 306 (31) 298 (32) 23 (22)
 Unknown 9 (1) 9 (1) 0 (0)
Normal ovary 15 15 0
Normal fallopian tube 3 3 0
Benign ovarian neoplasms 15 11 7
 Serous cystadenoma 6 6 1
 Mucinous cystadenoma 2 2 1
 Other 7 3 5
Borderline ovarian tumors 34 33 15
 Serous 26 26 9
 Mucinous 7 6 5
 Other 1 1 1
Sex cord stromal tumors 64 61 5
Germ cell tumors 49 47 2
Epithelial ovarian carcinoma 802 (100) 773 (100) 75 (100)
Grade
 1 133 (17) 132 (17) 23 (31)
 2 212 (26) 211 (27) 4 (5)
 3 437 (54) 420 (54) 48 (64)
 Unknown 20 (2) 10 (1) 0 (0)
Stage
 I 289 (36) 283 (37) 26 (35)
 II 93 (12) 91 (12) 6 (8)
 III 279 (35) 262 (34) 35 (47)
 IV 53 (7) 50 (6) 8 (11)
 Unknown or unstaged 88 (11) 87 (11) 0 (0)
Histology
 Serous 531 (66) 518 (67) 29 (39)
 Endometrioid 73 (9) 68 (8) 14 (19)
 Clear cell 58 (7) 56 (7) 8 (11)
 Mucinous 79 (10) 72 (9) 12 (16)
 Mixed/Other 61 (8) 59 (8) 12 (16)